Print Page  |  Contact Us  |  Sign In  |  Join ACAM
ACAM HQ Blog
Blog Home All Blogs

Proposed Membership Changes - 2nd Notice

Posted By Administration, Tuesday, October 25, 2016
Updated: Wednesday, December 28, 2016

 
VOTE ON PROPOSED MEMBERSHIP CHANGES
At the ACAM Board of Directors and Board Advisors meeting in Tucson, Directors reviewed proposed changes to ACAM's membership categories. Approved by the Board, the new membership categories now come to the members for vote of acceptance.
 

PROPOSED MEMBERSHIP CATEGORIES

This proposal was made to change the membership categories to meet today's marketplace.The primary goal is to enhance services ACAM provides to members at a level which meets  individual needs. This includes providing opportunities which are personalized, enhancing educational resources, presenting cutting edge techniques with training, and increasing integrative resources. With these important changes, ACAM may continue adding value which matters to members while keeping the ACAM community collaborative and vibrant. 


GENERAL MEMBER(voting rights)
  • MD, DO, ND, DDS, NMD*, NP, DC, PA, ARNP, Emeritus, & other similar
  • All one category - no US/International division
  • Dues tied to when member gained license
PREMIER MEMBER(voting rights)
  • MD, DO, ND, DDS, NMD*, NP, DC, PA, ARNP, Emeritus, & other similar
  • Added benefits from General Membership
ASSOCIATE MEMBER
  • PhD, DOM, ACAOM certified LAc, PharmD, RN, PAC, Psychologist, & other similar
INTEGRATIVE PROFESSIONAL MEMBER
  • Dietitian, Nutritionist, Acupuncturist, Nutritional Medical Doctor, Certified LMT, Pharmacist, & other similar
SCHOLAR MEMBER
  • Medical students in an accredited program, intern, resident, or fellow
CORPORATE MEMBER(1 vote)
  • Allows for 3 additional memberships with Physician+Link listings from same practice
  • Voting member must be MD, DO, ND, DDS, NP, DC, PA, ARNP, NDM, or Emeritus
EXPRESS MEMBER
  • Any General, Associate, Integrative Professional credential type
  • Online services only
 
VIEW PROPOSED BENEFITS
of each membership type

 VOTE NOW
You will be asked to provide your name and contact information so that we may verify votes - please provide at least your first and last name. Your vote is important!


This post has not been tagged.

Share |
PermalinkComments (0)
 

Proposed Membership Changes - 1st Notice

Posted By Administration, Friday, October 21, 2016
Updated: Wednesday, December 28, 2016

 
VOTE ON PROPOSED MEMBERSHIP CHANGES
At the ACAM Board of Directors and Board Advisors meeting in Tucson, Directors reviewed proposed changes to ACAM's membership categories. Approved by the Board, the new membership categories now come to the members for vote of acceptance.
 

PROPOSED MEMBERSHIP CATEGORIES

This proposal was made to change the membership categories to meet today's marketplace.The primary goal is to enhance services ACAM provides to members at a level which meets  individual needs. This includes providing opportunities which are personalized, enhancing educational resources, presenting cutting edge techniques with training, and increasing integrative resources. With these important changes, ACAM may continue adding value which matters to members while keeping the ACAM community collaborative and vibrant. 


GENERAL MEMBER(voting rights)
  • MD, DO, ND, DDS, NMD*, NP, DC, PA, ARNP, Emeritus, & other similar
  • All one category - no US/International division
  • Dues tied to when member gained license
PREMIER MEMBER(voting rights)
  • MD, DO, ND, DDS, NMD*, NP, DC, PA, ARNP, Emeritus, & other similar
  • Added benefits from General Membership
ASSOCIATE MEMBER
  • PhD, DOM, ACAOM certified LAc, PharmD, RN, PAC, Psychologist, & other similar
INTEGRATIVE PROFESSIONAL MEMBER
  • Dietitian, Nutritionist, Acupuncturist, Nutritional Medical Doctor, Certified LMT, Pharmacist, & other similar
SCHOLAR MEMBER
  • Medical students in an accredited program, intern, resident, or fellow
CORPORATE MEMBER(1 vote)
  • Allows for 3 additional memberships with Physician+Link listings from same practice
  • Voting member must be MD, DO, ND, DDS, NP, DC, PA, ARNP, NDM, or Emeritus
EXPRESS MEMBER
  • Any General, Associate, Integrative Professional credential type
  • Online services only
 
VIEW PROPOSED BENEFITS
of each membership type

 VOTE NOW
You will be asked to provide your name and contact information so that we may verify votes - please provide at least your first and last name. Your vote is important!
FOR REFERENCE: CURRENT MEMBERSHIP CATEGORIES

 
FULL MEMBERS(voting rights)
  • MD, DO, ND, DDS, NP, DC, PA, ARNP, Emeritus
  • US and International categories
ASSOCIATE MEMBERS
  • RN, PAC, Psychologist

AFFILIATE MEMBERS
  • PhD, DOM, LAc, PharmD
  • US and International categories
ADJUNCT MEMBERS
  • Retired, disabled, honorary
PHYSICIAN IN TRAINING
  • Students in an accredited program
INSTITUTIONAL
  • Academic Departments, Institutes, etc.
CORPORATE MEMBER

 The descriptions of each category is defined by the Board of Directors and expanded upon in the Policies and Procedures manual located, along with the bylaws, under ABOUT/Overview & Mission page on www.acam.org


This post has not been tagged.

Share |
Permalink
 

SHARE - DISTRIBUTE - SAVE: We need your help to prevent the death of natural medicine!

Posted By Liz Pullman, Wednesday, September 21, 2016
The US Food and Drug Administration (FDA) has issued its newly revised policy on nutritional supplements. It's effectively a death knell for the products you and your practice depend on to stay healthy naturally. Check out the attached flier and visit www.SaveSupplements.com for more information!

This post has not been tagged.

Share |
PermalinkComments (0)
 

Integrative Campaign Challenges FDA on Compounding Pharmacy

Posted By John Weeks, Publisher/Editor of The Integrator Blog News and Reports, Monday, August 8, 2016
The US Food and Drug Administration (FDA) is engaged in a regulatory process that will restrict the ability of integrative doctors to FDAindividualize their natural medicine prescriptions via the services of compounding pharmacies. The Integrative Medicine Consortium, (IMC) – with the American Association of Naturopathic Physicians (AANP) in a lead role – recently had success in saving access to one compounding agent. Yet the handwriting is on the wall. The AANP, working with the IMC and others, has announced a multi-year campaign to directly petition the FDA to maintain access to these agents.

Initial Steps

Pharmacy compounding is defined as “the art and science of preparing personalized medications for patients.” Medications are compounded based on a practitioner’s prescription “in which individual ingredients are mixed together in the exact strength and dosage form required by the patient.” According to the AANP, the development typically involves prescription “nutritional, herbal, and homeopathic remedies (that) are compounded to meet unique patient needs.” Large pharmaceutical manufacturers typically “do not have the skill nor interest to make small batches of these specialized products.” The AANP notes that “these compounded medications have also been used safely for decades.” Examples are thyroid and bioidentical hormones and various personalized mixes used in injections and chelation.

magazine coverThe FDA’s active antagonism began with an event in in 2012. Gross negligence at a compounding pharmacy, New England Compounding Center, led to a meningitis outbreak that was associated with 64 deaths and a great deal of additional morbidity. Two executives are currently facing murder charges and 12 others are charged in a 131-count indictment. The FDA’s effort since has been to shut down or severely curtail the industry.

Driving the campaign among integrative practitioners to make the case for general safety and to save access to compounding agents is Scottsdale, Arizona-based Michael Cronin, ND (pictured, left). Cronin is the current chair of IMC, past president of the AANP, former director of integrative medicine for American Whole Health, and founder of Southwest College of Naturopathic Medicine. He began promoting participation in FDA processes as chair of the AANP’s Compounded Medications Work Group. The stimulus was a proposed FDA guidance “that would greatly restrict the ability of physicians to administer compounded medications – including injectable and IV solutions – to patients in the office.” The AANP’s extensive documentation to the FDA defending the need for in-office use of these drugs fell on deaf ears.

One Agent at a Time

In late 2015, the FDA took an additional step to slam many doors. According to this article from the Alliance for Natural Health (ANH), an IMC affiliate, “the FDA released a list of nominations to its ‘Demonstrably Difficult to Compound’ (DDC) list … of drugs that cannot safely be compounded because of their complexity.” These are mainly the same agents that the AANP states “have been used safely for decades.”

The recent lone victory came at a June 2016 hearing before an FDA advisory panel where the AANP’s Paul Anderson, ND (pictured) andersonprovided expert testimony. Anderson’s medical group in Seattle includes the neuroscientist and multiple NIH-funded researcher Leanna Standish, PhD, ND, LAc. Following Anderson’s testimony, the AANP sent a note to its members announcing that on an 8-3 vote they had “scored a victory on June 23 with a successful defense of [the chelating agent] DMPS.” However, the notice went on, “many compounds – including MSM, curcumin, boswellia, germanium, and acetyl-l-carnitine – are being put on the FDA’s ‘do not compound’ list and the fate of many more remains undecided.” (Aloe vera is yet another agent determined to be unsafe.) The AANP then invited members to a July 25 webinar in which they offered further insight and reported on the planned campaign.

Despite the DMPS victory, Anderson painted a dire picture for webinar participants of likely chances for legal access to multiple other compounding agents. He noted that the FDA’s advisory committee only has one compounding pharmacist, a non-voting member. He added: “If you think the deck is stacked, this is just one element.” He added: “What the process is not – it is not a fair fight, not logical, not in service to patient care. It is not reasonable from the point of view of integrative medicine.” Reflecting on the poor ability of the science to shift the thinking of the advisory team, he added: “Data is not the issue. [The panel] is not reasonable.”

Hope: Petition(s) and Legal Campaign

Bottom line, as Anderson put it: “The FDA does not understand the value or the need for safely compounded medications. They view them as a public health threat.”

dumoffThe webinar presented a series of next steps based on the experience that AANP and IMC have gained through their engagement with the FDA. Longtime integrative health attorney Alan Dumoff (pictured, left) noted that the present work is building up the public record with scientific support for IMC/AANP views. Dumoff shared that over 30 separate organizations have been in touch with Congress to urge changes. Compounding pharmacies have also been active. An industry organization has organized a letter writing campaign to members of Congress that has gathered 61 signatures. (The Alliance for Natural Health has separately reported that a group of small compounders filed a suit against large suppliers for “unlawful insurance claim denials.”) Yet, the FDA has “ignored appeals” from Congress.

Dumoff and the AANP’s director of government affairs, Mike Jawer, argued that the time is right to petition the FDA – and also to potentially petition the Office of Management and Budget. In conjunction, a Freedom of Information Act request may be made. Cronin shared that the AANP has “pulled the trigger” on an aggressive fundraising campaign by providing an initial $10,000. An additional $4500 was raised from individuals on the call. Much more will be needed – up to an estimated $100,000 depending on the fate of the petition and the need for filing a lawsuit in Federal court. AANP is setting up a PayPal account to make it easy for integrative physicians to contribute. “This is about,” said Cronin, “owning our medicine.”

Comment: For most of us, the ins-and-outs of regulation around compounding medications were captured well by a blunt statement of Cronin. “This is complicated. It’s not a twitter feed.” One level of such complication, is cultural bias. Deaths associated with poor practice by a single compounding pharmacy in 2012 – horrible as they were – provoked this draconian move to narrow patient access to compounded medications. Imagine if the agency responded with as much vehemence to every procedure or practice that leads to the estimated 250,000 deaths associated with other medical errors. Good for IMC and the AANP to take this on. If interested in getting involved or supporting the cause, contact the AANP’s director of government affairs, mike.jawer@naturopathic.org.

This post has not been tagged.

Share |
PermalinkComments (0)
 

URGENT ACTION ALERT: Bad GMO Labeling Bill Fast-Tracked

Posted By Administration, Friday, July 1, 2016

On Wednesday, June 29th, members of Congress used a procedural trick to fast-track the new GMO labeling bill, meaning that this gift to Big Food and the biotech industry could be voted on as early as next week.

We must kill this bill. It allows industry to decide how to label its products, and you can bet that most companies will choose the option that requires consumers to scan a code or call a number to find out what's in their food. Companies know that few people will want to do this and even fewer will be able to.

Worse, there do not seem to be any penalties for a company that doesn't label its food. So for those who choose to simply ignore this law, there are very few consequences—unless the state separately imposes fines for mislabeling.

This bill is a wolf in sheep's clothing: it pays lip service to mandatory labeling but is designed to block Vermont's GMO labeling law and keep consumers in the dark about what's in their food.

Click the link below to tell your senators and the White House to vote NO on S. 764!

 

CLICK HERE to TAKE ACTION

This post has not been tagged.

Share |
PermalinkComments (0)
 

GETTING THE LEAD OUT: ACAM Offers Solution for Latest Round of National Lead Poisoning

Posted By Administration, Friday, March 4, 2016

In February Flint, Michigan declared a "State of Emergency" in the wake of lead contaminated drinking water. Now we’re hearing of lead poisoning in other areas across the United States, including Ohio, Pennsylvania and New Jersey. As a result, we are once again faced with the age-old discussion regarding the health implications of lead accumulation. We know that protecting all people from lead exposure is extremely important to lifelong good health. Children, however, are particularly vulnerable to the harmful effects of lead because they absorb lead much more readily than adults. The current controversy over treatment revolves around three questions:

  1. Who should be considered at higher risk for harm and offered treatment?
  2. What treatments should be offered to individuals with elevated lead levels?
  3. At what blood lead level burden is it appropriate to start therapy?

Unfortunately, this type of water crisis is not uncommon. People worldwide continue to be exposed to potentially harmful levels of many toxic metals that can profoundly affect their health. They face potentially enduring, serious and complicated health issues.  Perhaps the major question, especially in children, is the level of lead in the blood to cause concern.

The American College for Advancement in Medicine (ACAM), an educational organization and a leading authority in the field of metal toxicity and treatment believes, as the CDC does, that “no safe blood lead level in children has been identified.” The effects of lead exposure on child cognitive development and behavior may be permanent if no intervention occurs. Experts from ACAM believe that certain interventions may be useful in lessening the symptoms and long-term neurocognitive damage that lead causes in children.

ACAM experts also contend that the myriad, harmful effects that lead can cause in other organ systems in people of any age should also be lessened. The original guidelines for intervention in lead poisoning were based on early FDA drug approval studies from the minimal research conducted in pediatric patients with blood lead levels above 45 mcg/dL. ACAM believes that appropriate medical intervention may be beneficial to those suffering from lead levels even at the current CDC cutoff of 5 mcg/dl, the level that places the child in the upper 2.5% of tested individuals.

Practitioners can now take a more proactive approach to prevent permanent damage and disability due to toxic metal exposure. ACAM has announced two offerings of its national recognized Chelation Certification – now titled Chelation Advanced Provider (CAP) Course & Certification. Whether you’re new to detoxification education or a seasoned practitioner, ACAM’s rigorous CAP training will enhance your practice’s treatment options and improve health outcomes. One step cannot be completed without the other – this is a sequential course designed to provide the most in depth chelation training available to date.

As the recognized leader in metal detoxification/chelation therapy education, ACAM works diligently to ensure our curriculum is robust, relevant and of the highest caliber. The CAP Program covers a broad spectrum of detoxification topics for from biochemistry to billing. Our faculty ensure scientific rigor, complete understanding, and safe, practical application of therapy to maximize health worldwide.

“This is a chelation dream team,” Lyn Patrick, ND, co-chair of the ACAM Chelation Committee and co-organizer of the CAP Program said. The Basic Chelation Webinar Series (step 1 in the 3 step program) offers chelation insights and training from Tony Lamas, MD, FACC, FAHA, FESC, Dorothy Merritt, MD, David Quig, PhD, Walter Crinnion, ND, Jeffrey Morrison, MD, and Roy Heilbron, MD. The live training and certification exam (steps 2 and 3, offered in the spring and fall) give experts W.A. Shrader, MD, Merritt, Quig, Patrick, and Stuart Freedenfeld, MD time for didactic lectures and thorough back and forth question/answer time.

Registration for the spring CAP Training is currently open at www.acam.org/CAP. For more information or if you have questions, please contact ACAM at 1.800.532.3688 or email info@acam.org.

Tags:  Advanced Providers  CAP  chelation  chelation therapy  Flint  heavy metals  toxic 

Share |
PermalinkComments (0)
 

New Specialties Available for Member Profiles

Posted By Administration, Wednesday, February 24, 2016
A NOTE TO OUR MEMBERS:
About two dozen specialty services have been added to the ACAM.org Physician's Link search engine. Please log into your account and review your profile to see if you supply any of these services - you'll definitely want to update your profile to show you are a provider in your area. With over 1800 website hits per day, ACAM.org's Physician's Link is your key to online referrals.
REVIEW PROFILE NOW

This post has not been tagged.

Share |
PermalinkComments (0)
 

We Need Your Feedback for a Groundbreaking Study on Integrative Medicine

Posted By Administration, Tuesday, February 23, 2016
Dear ACAM Member:

You have been selected to participate in a groundbreaking study on the Integrative MD community. The American College for the Advancement of Medicine has partnered with Pure Branding, a leading wellness-focused research firm, along with other leaders in the Integrative Medicine community that you may also be affiliated with, to gain a better understanding of our community, so that we can continue to serve you as the field of integrative medicine continues to evolve and change the paradigm of healthcare in America. The information you provide will contribute greatly toward gaining further understanding of the needs and challenges of individual integrative physicians.

This is a comprehensive survey and should take you no longer than 20 minutes to complete. The information you provide will be kept completely confidential.

Please visit the following link to participate and let your voice be heard:
http://research.purebranding.com/s3/IMD-ACAM-4965123

Because the information you provide will be very insightful, and we know your time is valuable, we’d like to thank you for your efforts by offering the first 50 respondents who complete the survey with the choice of either $100 cash or a $100 credit toward the ACAM annual meeting registration fee. If you have already completed this survey, please disregard this notice.

Thank you in advance for your participation.
Sincerely,
ACAM Administration

This post has not been tagged.

Share |
PermalinkComments (0)
 

PRACTITIONERS UNITE: ACAM & AAPMD Come Together to Solve National Healthcare Crisis

Posted By Administration, Tuesday, February 16, 2016

The gap in education and acceptable practices in mainstream medicine have long concerned healthcare professionals. There is a definite need to learn from one another in hope the pioneers of integrative medicine can bring critical resources together to address the alarming rise of chronic disease.  You can't know what you don't know - join us to bridge this gap in information.

Conventional medicine or even the pieces of integrative medicine will not solve this crisis. The only way this national healthcare is collaborative care designed for the individual. These concerns will now be addressed as practitioners unite in the deserts of Tucson, AZ September 15-18, 2016.

ACAM and AAPMD - This partnership will create new treatment options worldwide! Yes, doctors,dentists and other healthcare practitioners are collaborating to bring hope to millions of patients facing the silent killers found in airway disorders. With airway disorders AAPMD will delve into the ongoing stressors of nutrition, internal/external environmental toxins, hormone imbalances and more. Today's complex multi-caused health problems required a team approach for the most complete, enduring result - we want to hear from you. Where has collaboration come into play within your practice? What recent case studies can you contribute to this effort?

Please join us as we work together to create intelligent healthcare practices and disseminate collaborative information to patients. Even the most cutting edge practitioner will benefit from collaborating with practitioners in other genres of medicine! We don't just talk about collaboration - we are living it! Join us in Tucson!

Tags:  AAPMD  ACAM  ACAM 2016 Annual Meeting  ACAM2016  Tucson 

Share |
PermalinkComments (0)
 

ACAM Addresses Flint, MI Water Crisis

Posted By Administration, Friday, January 22, 2016
Updated: Monday, February 8, 2016

Flint, Michigan recently declared a "State of Emergency" in the wake of lead contaminated drinking water. As a result, we are once again faced with the age-old discussion regarding the health implications of lead accumulation. We know that protecting all people from lead exposure is extremely important to lifelong good health. Children, however, are particularly vulnerable to the harmful effects of lead because they absorb lead much more readily than adults. The current controversy over treatment revolves around three questions:

  1. Who should be considered at higher risk for harm and offered treatment?
  2. What treatments should be offered to individuals with elevated lead levels?
  3. At what blood lead level burden is it appropriate to start therapy?

Unfortunately, this tragedy goes far beyond Flint, Michigan. People worldwide continue to be exposed to potentially harmful levels of many toxic metals that can profoundly affect their health. They face potentially enduring, serious and complicated health issues.  Perhaps the major question, especially in children, is the level of lead in the blood to cause concern.

The CDC states, “Experts now use a reference level of 5 micrograms per deciliter to identify children with blood lead levels that are much higher than most children’s levels. This new level is based on the U.S. population of children ages 1-5 years who are in the highest 2.5% of children when tested for lead in their blood.  In the past, blood lead level tests below 10 micrograms per deciliter of lead in blood may, or may not, have been reported to parents. The new lower value means that more children will likely be identified as having lead exposure allowing parents, doctors, public health officials, and communities to take action earlier to reduce the child’s future exposure to lead.”

The CDC also states, “What has not changed is the recommendation for when medical treatment is advised for children with high blood lead exposure levels. The new recommendation does not change the guidance that the therapy used to eliminate lead from the body be considered only when a child has been tested with a blood lead test result greater than or equal to 45 mcg/dL.” [http://www.cdc.gov/nceh/lead/ACCLPP/blood_lead_levels.htm]

However, medical science has determined that even very low blood lead levels in children can affect IQ, ability to pay attention and future academic achievement. It is now clear that IQ loss in lead-exposed children can occur at levels below 5.0 mcg/dL. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212280/, from Neurotoxicology, 2006 Sep; 27(5): 693–701.

The American College for Advancement in Medicine (ACAM), an educational organization and a leading authority in the field of heavy metal toxicity and treatment believes, as the CDC does, that “no safe blood lead level in children has been identified.” The effects of lead exposure on child cognitive development and behavior may be permanent if no intervention occurs. Experts from ACAM believe that certain interventions may be useful in lessening the symptoms and long-term neurocognitive damage that lead causes in children.

ACAM experts also contend that the myriad, harmful effects that lead can cause in other organ systems in people of any age should also be lessened. The original guidelines for intervention in lead poisoning were based on early FDA drug approval studies from the minimal research conducted in pediatric patients with blood lead levels above 45 mcg/dL. ACAM believes that appropriate medical intervention may be beneficial to those suffering from lead levels even at the current CDC cutoff of 5 mcg/dl, the level that places the child in the upper 2.5% of tested individuals.

Due to the lack of current, cohesive, long-term studies in children with elevated blood levels below 45 mcg/dL, the decision when to initiate chelation therapy is a personal choice between a patient and their physician. To better elucidate what is the best treatment strategy for lead poisoning, ACAM is calling for the immediate initiation of a collaborative long-term research project. The project, conducted through appropriate channels, could provide immediate medical attention and intervention to all children and adults in Flint who have high blood lead levels (>5 mcg/dl). This research project should also investigate assessing those common genetic and metabolic defects that could render individuals even more susceptible to the harmful effects of lead.

We can take a more proactive approach to prevent permanent damage and disability not only in the population of Flint, MI but to everyone exposed to the potential devastation caused by lead.

ABOUT ACAM:
The American College for Advancement in Medicine (ACAM) is a not-for-profit organization dedicated to educating physicians and other health care professionals on the safe and effective application of integrative medicine. ACAM's healthcare model focuses on prevention of illness and strives for total wellness. ACAM has been educating physicians in metal removal techniques such as chelation therapies since 1973. A recent NIH sponsored study has demonstrated that the chelation technique using EDTA is safe when it is used by physicians educated in these techniques.


FIND A PHYSICIAN NEAR YOU FOR ASSISTANCE:
ACAM offers Physician+Link – a free service provided to the public for finding integrative practitioners in their area. Call
1.800.532.3688 for personal assistance or visit www.acam.org/ACAMPL

ADDITIONAL RESOURCES:
A rationale for lowering the blood lead action level from 10 to 2 μg/dL

Effect of Chelation Therapy on the Neuropsychological and Behavioral Development of Lead-Exposed Children After School Entry

American Academy of Pediatrics: Lead Exposure in Children: Prevention, Detection, and Management

Safety and Efficacy of DMSA in children with elevated blood level concentrations

Children with moderately elevated blood lead levels: a role for other diagnostic tests?

What level of lead in blood is toxic for a child?

Tags:  chelation  detoxification  Flint  MI  Michigan  water 

Share |
PermalinkComments (0)
 
Page 2 of 3
1  |  2  |  3
Community Search
Sign In
Sign In securely
Calendar

9/14/2017 » 9/16/2017
ACAM 2017 Annual Meeting

Latest News